Brief: Moberg Pharma Q4 EBITDA Loss At SEK 5.7 Million
Aug 11 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* JUNE 2020
* Q4 NET REVENUE SEK 0.0 MILLION (0.0)
* Q4 EBITDA SEK -5.7 MILLION (-8.5)
Source text for Eikon: ID:nWkr7ZQJfh
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))